Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HORIZON-PFT: Pivotal Fracture Trial.

Trial Profile

HORIZON-PFT: Pivotal Fracture Trial.

Phase of Trial: Phase III

Latest Information Update: 11 Sep 2017

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Fracture; Postmenopausal osteoporosis; Vertebral fracture
  • Focus Registrational; Therapeutic Use
  • Acronyms HORIZON-PFT
  • Sponsors Novartis Pharmaceuticals
  • Most Recent Events

    • 16 Oct 2012 Extension study results presented at the 34th Annual Meeting of the American Society for Bone and Mineral Research.
    • 01 Aug 2012 Results published in the Journal of Bone and Mineral Research.
    • 24 Mar 2012 Results assessing renal function presented at the 2012 IOF World Congress on Osteoporosis and 11th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top